G. J. Lieschke and A. W. Burgess, Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (1), N Engl J Med, vol.327, pp.28-35, 1992.

G. J. Lieschke and A. W. Burgess, Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (2), N Engl J Med, vol.327, pp.99-106, 1992.

H. A. Jacene, T. Ishimori, J. M. Engles, S. Leboulleux, V. Stearns et al., Effects of pegfilgrastim on normal biodistribution of 18F-FDG: preclinical and clinical studies, J Nucl Med, vol.47, pp.950-956, 2006.

Y. Sugawara, K. R. Zasadny, P. V. Kison, L. H. Baker, and R. L. Wahl, Splenic fluorodeoxyglucose uptake increased by granulocyte colony-stimulating factor therapy: PET imaging results, J Nucl Med, vol.40, pp.1456-62, 1999.

R. Boellaard, R. Delgado-bolton, W. J. Oyen, F. Giammarile, K. Tatsch et al., EANM procedure guidelines for tumour imaging: version 2.0, Eur J Nucl Med Mol Imaging, vol.42, pp.328-54, 2015.

R. Boellaard, M. J. O'doherty, W. A. Weber, F. M. Mottaghy, M. N. Lonsdale et al., EANM procedure guidelines for tumour PET imaging: version 1.0, Eur J Nucl Med Mol Imaging, vol.37, pp.181-200, 2010.

M. E. Juweid, S. Stroobants, O. S. Hoekstra, F. M. Mottaghy, M. Dietlein et al., Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma, J Clin Oncol, vol.25, pp.571-579, 2007.

S. F. Barrington and R. Kluge, FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas, Eur J Nucl Med Mol Imaging, vol.44, pp.97-110, 2017.

J. M. Beauregard, M. S. Hofman, G. Kong, and R. J. Hicks, The tumour sink effect on the biodistribution of 68Ga-DOTA-octreotate: implications for peptide receptor radionuclide therapy, Eur J Nucl Med Mol Imaging, vol.39, pp.50-56, 2012.

N. Aide, C. Lasnon, P. Veit-haibach, T. Sera, B. Sattler et al., EANM/EARL harmonization strategies in PET quantification: from daily practice to multicentre oncological studies, Eur J Nucl Med Mol Imaging, vol.44, pp.17-31, 2017.
URL : https://hal.archives-ouvertes.fr/inserm-01856095

C. Lasnon, T. Salomon, C. Desmonts, P. Do, Y. Oulkhouir et al., Generating harmonized SUV within the EANM EARL accreditation program: software approach versus EARL-compliant reconstruction, Ann Nucl Med, vol.31, pp.125-159, 2017.

T. Salomon, C. Nganoa, A. C. Gac, C. Fruchart, G. Damaj et al., Assessment of alteration in liver (18)F-FDG uptake due to steatosis in lymphoma patients and its impact on the Deauville score, Eur J Nucl Med Mol Imaging, vol.45, pp.941-50, 2018.
URL : https://hal.archives-ouvertes.fr/inserm-01856020

W. C. Tsoi, K. F. To, and C. S. Feng, Splenic hematopoiesis after granulocyte-colony stimulating factor therapy in a lupus patient, Am J Hematol, vol.53, pp.283-287, 1996.

X. Wu, A. Bhattarai, P. Korkola, H. Pertovaara, H. Eskola et al., The association between liver and tumor [18F]FDG uptake in patients with diffuse large B cell lymphoma during chemotherapy, Mol Imaging Biol, 2017.

B. K. Teo, S. Badiee, M. Hadi, T. Lam, L. Johnson et al., Correcting tumour SUV for enhanced bone marrow uptake: retrospective 18F-FDG PET/CT studies, Nucl Med commun, vol.29, pp.359-66, 2008.

, Publisher's Note

, Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations